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Abstract
We tested the hypothesis that modulation of monoaminergic tone with deep-brain stimulation (DBS) of subthalamic
nucleus would reveal a site of reactivity in the ventromedial prefrontal cortex that we previously identified by modulating
serotonergic and noradrenergic mechanisms by blocking serotonin-noradrenaline reuptake sites. We tested the hypothesis
in patients with Parkinson’s disease in whom we had measured the changes of blood flow everywhere in the brain
associated with the deep brain stimulation of the subthalamic nucleus. We determined the emotional reactivity of the
patients as the average impact of emotive images rated by the patients off the DBS. We then searched for sites in the brain
that had significant correlation of the changes of blood flow with the emotional impact rated by the patients. The results
indicate a significant link between the emotional impact when patients are not stimulated and the change of blood flow
associated with the DBS. In subjects with a low emotional impact, activity measured as blood flow rose when the electrode
was turned on, while in subjects of high impact, the activity at this site in the ventromedial prefrontal cortex declined when
the electrode was turned on. We conclude that changes of neurotransmission in the ventromedial prefrontal cortex had an
effect on the tissue that depends on changes of monoamine concentration interacting with specific combinations of
inhibitory and excitatory monoamine receptors.
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Introduction
We have shown that activity in a circumscribed region of the
medial prefrontal cortex undergoes a change of activity when the
region is challenged by administration of the serotonin-noradren-
aline reuptake inhibitor clomipramine. In this previous study (File
S1), the change of activity in each subject correlated inversely with
the emotional impact of standardized emotive images presented to
the subjects in separate sessions [1]. In that study, we proposed
that the inverse relation is linked to differential distributions of
inhibitory and excitatory monoamine receptors in this region.
Because of the close relations between the serotonergic, norad-
renergic, and dopaminergic systems, we further speculated that a
general mechanism would link monoaminergic tone and emo-
tional reactivity in this specific region.
Serotonergic, noradrenergic and dopaminergic mechanisms
interact closely in the frontal cortex. Stimulation of the majority
of serotonergic receptors (5-HT1A,5 - H T 1B, 5-HT2A,5 - H T 3 and 5-
HT4)receptorsfacilitatesdopamine (DA)release,with theexception
of the 5-HT2C receptors that strongly inhibit DA release in the
ventral tegmental area but have no effect on DA release in the
frontal cortex [2,3]. In the frontal cortex, the serotonin receptors
facilitate the release of dopamine from the terminals of fibres that
arise in the midbrain [4]. We speculate that the effects of this
dopamine release depend on the differential distributions of D1 and
D2 receptors that respectively facilitate and inhibit the excitability of
the neurons on which these receptors reside.
Previously, we showed that patients with Parkinson’s disease
display certain forms of disordered cognition when they are
treated with deep brain stimulation (DBS) [5]. Here we test the
hypothesis that an alleged modulation of monoaminergic tone in
patients with Parkinson’s disease would reveal the level of
emotional reactivity of neurons in ventromedial prefrontal cortex,
in a manner similar to that seen during the alleged modulation of
serotonergic and noradrenergic tone that occurs after blockade of
serotonin-noradrenaline reuptake sites.
Methods
To test if emotional reactivity relates to changes of neurotrans-
mission in the prefrontal cortex, we obtained PET images of the
effect of DBS of the subthalamic nucleus on the cortical activity in
seven patients suffering from Parkinson’s disease. The patients were
approached by one of the authors (JG) of this study and gave written
informed consentto the procedures specified in a protocolapproved
by the official Central Danish Regional Science Ethics Committee.
We correlated the changes of activity in these images with the
ratings of emotional impact of standardized emotive images
recorded by the patients. Selected details of the patients’ condition
including medication are given in Table 1. Greater details of the
patients’ history, treatment and DBS were reported by Geday et al
[5]. The positions of the electrodes are shown in Figure 1: The
stimulus conditions are given in Table 2, and effects on the
UPDRS-III rating scale are given in Table 3.
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oxygen-15-labeled water were given by Geday et al. [5,6] and
Geday and Gjedde [1]. We analyzed the PET images of blood
flow on and off the DBS and determined the changes of blood flow
elicited by the DBS in a 6 mm radius sphere centred on the
Talairach coordinates (1, 55, 213, x,y,z mm), identified as the site
of the previously reported interaction between serotonergic-
noradrenergic tone and emotional impact [1]. During the PET
measurements, the subjects passively viewed the images of the
standardized Empathy Picture System (EPS) [7], as described by
Geday et al [5].
We correlated the change of blood flow with the emotional
impact of the emotive images in the seven patients. We recorded
the emotional impact of the images in a separate session with the
DBS stimulation off and on, respectively. As in the study reported
by Geday and Gjedde [1], we defined the impact as the numerical
difference between ratings of unpleasant and pleasant images
included in the standardized Empathy Picture System in the
separate session with the subjects off and on the DBS.
We analyzed the PET images by voxel-wise regression of PET
volumes with local voxel SD estimates against the ratings of
emotional impact, as implemented in the Dot statistical parametric
mapping of the Montreal Neurological Institute [8], to identify all
cortical areas where DBS effects (DrCBF/rCBF), defined as the
relative rCBF change associated with an intervention or challenge,
correlated with emotional impact. We accepted only changes with
t.4.5 or t ,4.5 (corrected for multiple comparisons) as having
reached significance (P,0.05) with 46 degrees of freedom and a
search volume 600 cm
3 for all cortical gray matter at an FWHM
of 12 mm.
In addition to the global analysis of all cortical gray matter
(excluding the cerebellum), we restricted a search to a volume of
interest (VOI) consisting of one 6-mm-radius sphere centered on a
site in the right inferior medial prefrontal cortex (IMPC) previously
shown to be deactivated by emotional content [1,5–7] at the
Talairach coordinates (x, y, z mm) 1, 55, 213. Threshold t-
statistics of the restricted search was 3.46 for P,0.05 with 46
degrees of freedom with a search volume of 0.984 cm
3 at an
FWHM of 12 mm.
Results
We completed the regression analysis of blood flow changes
elicited by STN stimulation against emotional impacts ratings,
equal to the difference between ratings of pleasant images and
ratings of unpleasant images, on a scale from 23t o+3 in the seven
subjects. The regression revealed several sites in which the
correlation between the two measures reached significance
(P,0.05, corrected for multiple comparisons). The correlation is
shown as negative in Figure 2, indicated by the negative t-value
bars. The negative correlation implies that increases of blood flow
occur at the low end of the emotional impact ratings.
One of the sites at which blood flow underwent this change
associated with the DBS in correlation with emotional impact
coincided with the area at which blood flow equally underwent a
change during the clomipramine challenge reported by Geday and
Gjedde [1], in both cases in inverse proportion to the emotional
impact of the emotive images presented in the absence of a drug
challenge or electrical stimulation. This previously reported site is
in the region of Brodmann’s Area (BA) 11, centred on the
Talairach coordinates (1, 55, 213 [x,y,z] mm),
We specifically determined the change of relative blood flow
values at this site in a specific volume-of-interest with a radius of
6 mm, centred on the previously identified coordinates, as shown
in Figure 1. These changes are listed in Table 4, together with the
ratings of emotional impact with the electrodes off and on. When
we compared the blood flow changes in this region with the ratings
of emotional impact, we found significant correlation (P=0.027)
between the blood flow change elicited by the DBS and the ratings
of emotional impact with the DBS off, as shown in Figure 3. The
same comparison with the ratings of emotional impact with the
DBS on did not quite reach significance (P=0.12). With the mean
of the off and on ratings, the significance increased further
(P=0.019). While this implies that the change of emotional impact
ratings with stimulation failed utterly to reach significance
(P=0.94), we note that the ratings of emotional impact on and
off DBS in five of the seven subjects changed in parallel with the
Figure 1. Electrode placement coordinates for the seven
subjects studied in this investigation. Electrode positions of the
7 patients entered into the study in the coronal and axial planes.
doi:10.1371/journal.pone.0008120.g001
Table 1. Population characteristics and medication.
Subject
No. sex age (years) parkinson medication
*Most
affected side
1 male 68 pramipexole, levo-dopa R
2 male 58 pramipexole, levo-dopa L
3 male 55 pergolide, levo-dopa L
4 male 65 ropinirole, levo-dopa R
5 female 66 levo-dopa R
6 male 53 pramipexole, levo-dopa,
entacapone
L
7 male 62 pergolide, levo-dopa R
*) Most affected side before STN-operation.
doi:10.1371/journal.pone.0008120.t001
DBS of Emotional Impact
PLoS ONE | www.plosone.org 2 December 2009 | Volume 4 | Issue 12 | e8120change of blood flow at this site, relative to whole-brain. These five
subjects are marked with an asterisk in Table 1.
Discussion
The results support the predicted link between the emotional
impact of emotive images and changes of activity in the prefrontal
cortex associated with specific drug challenge or electrode
stimulation. Thus, in subjects with a low emotional impact,
activity measured as blood flow at a site in the ventromedial
prefrontal cortex rose in patients with Parkinson’s Disease and
DBS electrode turned on, as it did in healthy subjects challenged
with a serotonin-noradrenaline reuptake inhibitor, while in
patients of high impact, the activity at this site in the ventromedial
prefrontal cortex declined when the electrode was turned on, as it
did in healthy subjects of high impact challenged with the drug.
We explain the findings in both groups by the claim that
monoamines (serotonin, noradrenaline, or dopamine) are released
from terminals in the ventromedial prefrontal cortex and that this
release has an effect on the emotional reactivity that depends both
on the monoamine concentration and on the relative distributions
of inhibitory and excitatory dopamine receptors.
In the previous study [1], we considered the theoretical
consequences of the well-known presence of two major popula-
tions of monoaminergic receptors, of which one class is inhibitory
and the other class is excitatory. Examples include the serotonin
receptors among which the 5HT1A receptors mediate lower
excitability and most other serotonin receptors mediate higher
excitability of the cells where they reside, and the dopaminergic
receptors among which the D1 receptors when occupied
contribute to raised excitability and the D2 receptors when
occupied lower the excitability of the cells on which they reside.
The direction of the effect (inhibitory or excitatory) of an
increment of endogenous ligand occupation then depends on the
baseline ligand concentration from which the increment occurs. At
low concentrations, the effect of an increment is in one direction,
depending on the distribution of excitatory and inhibitory
receptors. At concentrations above a certain threshold, the effect
of the increment is in the opposite direction. The net effect of the
transmitter release therefore reflects the pre-existing transmitter
concentration in relation to the receptor distribution, as well as the
magnitude of the increment.
Geday et al. [5] reported the results of a different setup in which
patients off medication and stimulation, who passively viewed
emotionally pregnant scenes relative to neutral scenes had
significantly less activation of the right inferior temporal cortex
and significantly greater activation of the left anterior cingulate
gyrus than healthy volunteers. The result refers to an effect of the
emotional impact on the measured change of blood flow in PD
compared to control. Although there is no blood flow measure-
ment in the present study in conjunction with the rating of the
images, the 2006 findings in relation to the present findings could
mean that DBS of the STN restores a habitual sensitivity by reac-
tivation of affected mechanisms of emotional impact processing.
What is the evidence that there is monoamine release in the
ventromedial prefrontal cortex or elsewhere during DBS? One
PET study of the binding of the D2 receptor radioligand raclopride
in the striatum [9] did not give evidence consistent with increased
extracellular dopamine in the striatum during stimulation of the
subthalamic nucleus (STN-DBS) in humans. However, other
studies strongly indicate that STN-DBS does increase the release
of dopamine, measured either directly by means of microdialysis
[10,11] or indirectly by means of raclopride and PET [12]. None
of these studies provided direct evidence of dopamine release in
the ventromedial prefrontal cortex, where the density of dopamine
receptors is too low to accurately record the changes of binding
with raclopride.
However, considerable circumstantial evidence links dopamine
release in the prefrontal cortex to the regulation of emotive and
cognitive functions subserved by this part of the brain. In rats,
Bean et al. [13] used microdialysis to measure extracellular
concentrations of dopamine and neurotensin in the rat prefrontal
cortex during electrical stimulation of the median forebrain
bundle. The stimulation released both dopamine and neurotensin.
In rat prefrontal cortex, dopamine strongly modulates long-term
Table 2. STN-DBS settings.
Patient left electrode right electrode unipolar
volt pulse width (msec) rate Hz mAmp Ohm volt pulse width (msec) rate Hz mAmp Ohm
1 3,0 60 195 39 890 3,3 60 200 39 890 yes
2 2,5 60 135 30 670 3,7 60 135 30 1000 yes
3 3,5 60 160 36 945 2,9 60 160 36 780 yes
4 3,5 60 180 36 1042 3,4 60 180 36 1012 yes
5 2,0 60 130 29 532 1,2 60 130 29 670 yes
6 3,3 60 160 30 981 3,3 60 160 30 981 yes
7 2,9 60 170 24 1471 3,2 60 170 42 843 Yes
doi:10.1371/journal.pone.0008120.t002
Table 3. STN efficacy measured as difference in motor scores
on the Unified Parkinson’s Disease Rating Scale (UPDRS III).
Subject No. UPDRS III ‘‘OFF’’ UPDRS III ‘‘ON’’ Effect (ON – OFF)
14 0 2 2 1 8
21 8 7 1 1
36 5 1 2 5 3
44 8 8 4 0
51 4 4 1 0
63 7 2 0 1 7
73 1 1 2 1 9
Mean 36,1617,5 12,166,7 24616,2 (66%
improvement)
doi:10.1371/journal.pone.0008120.t003
DBS of Emotional Impact
PLoS ONE | www.plosone.org 3 December 2009 | Volume 4 | Issue 12 | e8120depression (LTD) and potentiation (LTP) of glutamatergic
synapses. Otani et al. [14] reported that the dopaminergic
facilitation of LTD in part is triggered by dopamine receptor
activation. Lewis et al. [15] confirmed that stimulation of the
ventral tegmental area leads to states of depolarization of
pyramidal neurons in the prefrontal cortex that are blocked by
antagonists of the D1 receptors, indicating that the increased
excitability is due to release of dopamine. During high frequency
stimulation of the STN in rats, intracellular recordings from
dopaminergic neurons in substantia nigra pars compacta by Lee et
al. [16] revealed increased generation of EPSPs and increased
frequency of action potentials. In patients with Parkinson’s disease,
Jahanshahi et al. [17] observed that DBS of the STN improved
cognitive skills assessed by standard neuropsychological tests. In
three patients with treatment resistant depression implanted with
bilateral DBS electrodes in the nucleus accumbens, significant
changes of brain metabolism were observed in frontostriatal
networks, associated with improvements of anhedonia which is a
key deficiency in refractory major depression [18].
Together these studies provide a strong basis for the claim that
DBS of the STN directly or indirectly leads to release of
monoamines in the ventromedial prefrontal cortex, the effect of
which is contingent upon the quantity of monoamines released
and the relative densities of excitatory and inhibitory monoamine
receptors, with important consequences for the emotional impact
of emotive sensations.
Supporting Information
File S1 Related paper by authors. This is a recently published
paper to which the submitted ms refers
Found at: doi:10.1371/journal.pone.0008120.s001 (0.24 MB
PDF)
Table 4. Emotional reactivity and normalized brain activity.
subject
emotional
reactivity change
activity (whole brain
average 100) change
off STN-
DBS
on STN-
DBS
off STN-
DBS
on STN-
DBS
1 3.80 3.65 20.15* 102.811 90.700 212.111*
2 3.77 2.79 20.98* 132.000 124.214 27.786*
3 2.69 2.30 20.39* 118.469 116.799 21.670*
4 3.12 3.07 20.05 127.382 128.639 1.258
5 3.00 3.70 0.70* 116.846 118.504 1.658*
6 2.37 3.37 1.00* 108.837 111.234 2.397*
7 2.17 1.89 20.28 89.130 117.006 27.876
doi:10.1371/journal.pone.0008120.t004
Figure 3. Significant change of blood flow in response to deep
brain stimulation. Changes of blood flow at site in ventromedial
prefrontal cortex in relation to separately recorded emotional impact.
Abscissa: Individual emotional reactivity scores (ratings of pleasant
images minus ratings of unpleasant images from the EPS). Ordinate:
Blood flow change in 6-mm sphere centred at Talairach coordinates (1,
55, 213, x,y,z mm) elicited by STN-DBS.
doi:10.1371/journal.pone.0008120.g003
Figure 2. Sites of significant correlation of emotional impact and blood flow changes by deep brain stimulation. Green scale: Areas in
the cortex with significant correlation of emotional impact and blood flow change elicited by STN-DBS. A region centred on Talairach coordinates 1,
55, 213, (x,y,z mm) is marked by yellow circle. The threshold in the images is P,0.05 for t,24.50. Red scale: Areas in the frontal cortex with an
interaction between emotional reactivity and blood flow changes elicited by a clomipramine challenge [1]. The area of significant interaction
(threshold P,0.05 for t,23.46) in BA11 partially coincides with the area of interaction between STN-DBS and emotional impact.
doi:10.1371/journal.pone.0008120.g002
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